🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the safety and efficacy of adalimumab...
Status
Completed
Location
Site Reference ID/Investigator# 322
Start Date
2000-12
Trial ID
NCT00195663
Treatments Being Tested
The study involves approximately 105 adolescent (ages 12-17) subjects to be...
Status
Completed
Location
Premiere Research Institute
Start Date
2010-03
Trial ID
NCT01016678
This is a Phase IV, randomized, double-blind, parallel-group, multiple-dose...
Status
Completed
Location
SB Investigative Site
Start Date
2022-08-04
Trial ID
NCT05510063
Treatments Being Tested
This is a randomized, double-blind, very low dose parallel-controlled, pros...
Status
Completed
Location
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Start Date
2024-08-14
Trial ID
NCT06551675
Treatments Being Tested
PRO-BOOST-LC is a prospective, multicenter, randomized phase II/III clinica...
Status
Recruiting
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Start Date
2026-03-19
Trial ID
NCT07426055
The primary aim of the DahLIA trial is to determine, in patients with ICU-a...
Status
Completed
Location
Royal North Shore Hospital
Start Date
2011-02
Trial ID
NCT01151865
Treatments Being Tested
VAM00001 is a Phase I/II, randomized, modified double-blind, multi-center s...
Status
Completed
Location
Centricity Research-Mesa Site Number : 8400006
Start Date
2022-11-03
Trial ID
NCT05608005
Treatments Being Tested
The purpose of this clinical trial is to compare drug combinations to learn...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2025-07-25
Trial ID
NCT06859424
Treatments Being Tested
This is a first in human study to determine the safety, tolerability, pharm...
Status
Terminated
Location
Celerion
Start Date
2018-06-07
Trial ID
NCT03571594
Treatments Being Tested
This is a 12 week study in which different doses and formulations of UK-369...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-05
Trial ID
NCT00457457
Treatments Being Tested